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Abstract
Background—Amazonian populations are exposed to diverse parasites and pathogens, including 
protozoal, bacterial, fungal, and helminthic infections. Yet much of our understanding of the 
immune system is based on industrialised populations where these infections are relatively rare.
Aim—We examine distributions and age-related differences in 22 measures of immune function 
for Bolivian forager-horticulturalists and US and European populations.
Subjects and Methods—Subjects were 6,338 Tsimane aged 0–90 years. Blood samples 
collected between 2004–2014 were analysed for 5-part blood differentials, C-reactive protein, 
erythrocyte sedimentation rate (ESR), and total immunoglobulins E, G, A, and M. Flow cytometry 
was used to quantify naive and non-naïve CD4 and CD8 T cells, natural killer cells, and B cells.
Results—Compared to reference populations, Tsimane have elevated levels of most 
immunological parameters, particularly immunoglobulins, eosinophils, ESR, B cells, and natural 
killer cells. However, monocytes and basophils are reduced and naïve CD4 cells depleted in older 
age groups.
Conclusion—Tsimane ecology leads to lymphocyte repertoires and immunoglobulin profiles 
that differ from those observed in industrialised populations. These differences have consequences 
for disease susceptibility and co-vary with patterns of other life history traits, such as growth and 
reproduction.
*Corresponding authors: Aaron Blackwell: blackwell@anth.ucsb.edu, Hillard Kaplan: hkaplan@unm.edu, Michael Gurven: 
gurven@anth.ucsb.edu. 
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Introduction
The Amazon River basin is home to an astonishing degree of biodiversity. It is the world’s 
largest rain forest, and includes over 2,000 species of birds and mammals. An estimated 10% 
of the world’s species live in Brazil alone (Lewinsohn, 2005), and the Amazon basin is 
home to an estimated 400 indigenous tribes (http://www.survivalinternational.org/). 
Unfortunately for Amazonian peoples, this diversity includes an exceptional array of 
pathogens and parasites (Dunn et al., 2010), including soil-transmitted helminths and filarial 
nematodes, protozoa, amoebas, bacteria, viruses, lice and scabies, and mycoses (Salzano and 
Callegari-Jacques, 1988; Martin et al., 2013). Despite the recognition that a large number of 
micro- and macro-parasite species coexist in the Amazon biome where people have lived for 
millennia, little data exists documenting how immune function develops and senesces in 
Amazonian and other tropical populations. Characterisation of immune function in 
Amazonians is important both for documenting human biological diversity and for 
understanding and addressing the health challenges facing Amazonian peoples. 
Understanding how immune function responds to ecological conditions also bears on 
questions of human life history evolution, as immune responses and disease impact profiles 
of growth, reproduction, senescence and mortality (McDade, 2003; Blackwell et al., 2010, 
2015; Pisor et al., 2013).
The Tsimane are an Amazonian population indigenous to the Bolivian lowlands. Previous 
studies have documented high prevalences of helminthic, protozoal, fungal, and other 
infections in Tsimane of all ages (Martin et al., 2013). Tsimane also have much higher levels 
of several immune markers, including immunoglobulin E (IgE) (Blackwell et al., 2011), 
total leukocyte count, and erythrocyte sedimentation rates (ESR) (Gurven et al., 2009). Here, 
we expand upon these findings to provide a “thick description” of Tsimane immune function 
by characterising levels of 22 immunological parameters in reference to clinical values from 
the United States and Europe. Since the immune system is multifaceted, there are a vast 
number of biomarkers that might be measured to fully characterise it, but past studies of the 
Tsimane and other populations have relied primarily on one or two measures of immune 
function. Thus, while these results are informative, they fail to provide a comprehensive 
picture of immune function in a traditional population. Moreover, reliance on single 
measures may sometimes lead to incorrect conclusions if they are taken to represent the 
immune system as a whole, since trade-offs may be evident between multiple branches of 
immunity (McDade, 2005; Blackwell et al., 2010). Below, we briefly review the aspects of 
immune function considered in this paper and then describe the pathogenic environments of 
the Tsimane and other Amazonian peoples. We then present our results describing Tsimane 
immune function and discuss the implications of these results for life history tradeoffs and 
the health of Amazonian peoples.
A multifaceted and plastic immune system
Although often conceptualised as a single system, the immune system is actually a complex 
suite of diverse responses specialised for different tasks. As such, these responses have 
different costs and benefits for dealing with and preparing for particular threats, and trade-
offs exist between branches of immune function. Organisms are expected to regulate 
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immune function carefully because responding to disease is costly: immune responses use 
energy that could be used for other fitness relevant demands; many responses have the 
potential to cause collateral damage to the organism itself (Ashley et al., 2012); and illness 
can involve opportunity costs due to sickness behavior (e.g. reduced productivity) (Stieglitz 
et al., 2015b). Across species, mounting an immune response decreases growth and 
reproduction, as resources used for immunity are not available for these competing demands 
(Sheldon and Verhulst, 1996; Klein and Nelson, 1999; Uller et al., 2006; Blackwell et al., 
2010; Abrams and Miller, 2011). Since different aspects of immune defense have their own 
costs and benefits, across species natural selection will have acted on patterns of 
responsiveness, determining the relative proportions and strengths of responses to employ. 
Within species, natural selection is likely to have shaped immunological reaction norms 
determining how phenotypes vary in response to environmental cues (McDade, 2003; 
Ashley et al., 2012).
Differences in parasite and pathogen exposure have been a major force shaping genetic 
variation across human populations (Fumagalli et al., 2011; Karlsson et al., 2014), and most 
immune function parameters have a heritable component, including IgE levels (Grant et al., 
2008), baseline C-reactive protein (CRP) (Retterstol et al., 2003; Wu et al., 2012), and 
lymphocyte percentages (Hall et al., 2000). However, heritability estimates for immune 
function parameters are generally in the range of 30% – 60%, even when environmental 
variance is low and pathogen exposure limited (Brodin et al., 2015). This suggests that most 
of the variance in human immune function is attributable to environmental factors or 
reaction norms.
Table 1 describes the diverse immunological parameters measured in this study. They can be 
categorised in a variety of ways, but one fundamental distinction is between innate and 
adaptive immunity. With short generation times, pathogens evolve faster than the hosts they 
infect. To counteract this, the adaptive immune system evolved to generate variation in 
immunity within individual lifetimes, by randomly reorganising gene segments for 
immunoglobulins and T cell receptors and then selecting the most useful variants from this 
large pool (Flajnik and Kasahara, 2010). Levels of immunoglobulins, T cells, and B cells can 
be used to characterise investment into adaptive immunity, with T and B cells further 
separated into naïve cells, which represent the size of the random pool generated in 
preparation for pathogenic threats an organism has not yet encountered, and non-naïve cells, 
which represent protection against pathogens previously encountered in an organism’s 
lifetime.
Innate defenses are generic, non-specific defenses that do not need to be acquired over the 
lifetime. Innate defenses include both non-cellular defenses such as fever, CRP, and 
fibrinogen, and cellular defenses such as neutrophils, monocytes, and natural killer cells. 
Innate and adaptive immunity work together, and functional immune responses depend on 
both types of response. Yet, several lines of evidence suggest that organisms might vary their 
relative investment in and reliance on innate versus adaptive immunity depending on their 
life histories, ontogenetic influences, and environmental circumstances (McDade et al., 
2016). For example, compared to specific responses, non-specific inflammatory responses 
are more likely to cause collateral damage through oxidative stress, and are associated with 
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long-term risks of several chronic diseases, including atherosclerosis, cardiovascular disease, 
obesity, and depression (Ridker et al., 1998; Pearson et al., 2003; Stieglitz et al., 2015b). An 
inflammatory response is often the body’s first line of defense against infections and 
wounds, and the strength of the response is expected to vary based on ecological and 
phenotypic conditions. If an organism has low energy stores or high extrinsic mortality risk, 
prolonged inactivity and illness might otherwise limit mating opportunities or result in fatal 
energy shortages. Thus innate defenses which can quickly clear a pathogen, such as 
inflammation, may be preferred. In longer living organisms with lower mortality risk and 
sufficient energy stores for prolonged immune activation, defenses that limit collateral 
damage may be preferred, even if they take longer to achieve pathogen clearance (Martin et 
al., 2008; Previtali et al., 2012). For these organisms, investing in slower more specific 
defenses may take precedence over investing in immediate, high cost innate responses. 
Similarly, organisms exposed to a high diversity of pathogens and parasites should invest 
more in generating diverse pools of naïve T and B cells, and should maintain larger pools of 
memory cells, particularly if diverse exposure is coupled with repeated exposure to the same 
pathogens over time, or if exposures occur earlier in life when developmental trajectories are 
determined.
The Tsimane
The Tsimane are a rapidly expanding (3.6% annual growth rate (Gurven et al., 2014)) 
population of about 15,000 semi-sedentary forager-horticulturalists that live in over 90 
villages along the Maniqui River and surrounding areas in lowland Beni, Bolivia. Tsimane 
subsist by hunting, fishing, and cultivation of plantains, rice, corn and manioc. Their diet 
consists of 74% plant products and 26% animal products, with <10% of calories coming 
from purchased foods (Martin et al., 2012). In general, Tsimane are short and lean, but not 
undernourished (Foster et al., 2005). Tsimane are predominately a natural fertility 
population, with a total fertility rate of 9.1 births per woman (Gurven et al., 2007; 
McAllister et al., 2012; Blackwell et al., 2015). Tsimane breastfeed their infants on-demand, 
with a mean weaning age of 19 months (Veile et al., 2014).
Tsimane are exposed to a wide array of pathogens and parasites, including high prevalences 
of hookworm (50%), giardia (37%), and roundworm (15%) that persist despite annual 
treatment by physicians working on the Tsimane Health and Life History Project (THLHP) 
(Blackwell et al., 2013; Martin et al., 2013). Common afflictions include upper and lower 
respiratory infection, gastrointestinal problems, skin infections, urinary tract infections, and 
traumatic injuries. During annual medical visits conducted by the THLHP (www.unm.edu/
~tsimane), 75% of adults report being sick enough to remain in bed for the day at least once 
in the last three months (Gurven et al., 2012b). Tsimane are also exposed to a variety of 
sexually transmitted diseases (Stieglitz et al., 2012). Prior to 1990, approximately 14% of 
infants died in their first year (Gurven et al., 2007), and infant mortality remains relatively 
high in recent years at 4.6% (Kaplan et al., 2015). Using retrospective data, about half of 
Tsimane deaths between 1950–2000 were due to infectious disease (Gurven et al., 2007). A 
more recent analysis of deaths occurring between 2005–2010 similarly shows that 50% of 
deaths were due to infectious disease (unpublished data). Retrospective demographic 
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interviews and recent THLHP medical exams utilising thoracic computed tomography scans 
also attest to untreated tuberculosis as a ubiquitous problem for older Tsimane.
Health in Amazonian populations
Although diversity in diet and residential mobility exists among indigenous Amazonian 
populations, with many living as sedentary or semi-sedentary slash-and-burn 
horticulturalists, others as peasant agriculturalists, or as mobile foragers, there are 
similarities common to most Amazonians inhabiting similar mixed neotropical, subtropical, 
and savanna biomes. Extremely high levels of IgE, indicative of parasite infections, have 
been documented in indigenous groups in Venezuela, Ecuador, and Bolivia (Blackwell et al., 
2010; Martin et al., 2013). High prevalences of helminth infection, particularly Ascaris 
lumbricoides, have been documented in the Shuar of Ecuador, Yanomamo of Brazil, and 
many other Amazonian populations (Salzano and Callegari-Jacques, 1988; Hurtado et al., 
2008; Cepon-Robins et al., 2014). Tuberculosis is prevalent and a source of morbidity and 
mortality in many indigenous South American populations (Hill and Hurtado, 1996; Hurtado 
et al., 2004). Skin diseases, including abscesses, leishmaniasis, and fungal infections are 
common (Salzano and Callegari-Jacques, 1988; Hern, 1991; Martin et al., 2013). Thus, 
although this study focuses on a single population, its results have broader implications for 
understanding health and well-being of numerous Amazonian populations.
The present study
Given their pathogenic environment we propose that Tsimane immune function is 
characterised by differences in the distributions and age profiles of many biomarkers when 
compared to US and European populations. Previous studies have documented high IgE, 
leukocyte counts, and ESR in Tsimane, but have not examined leukocyte subsets or other 
immunoglobulins, or described how all of these parameters differ by age cohorts. Here we 
measure and describe Tsimane child and adult blood differentials, CRP, ESR, and four 
classes of immunoglobulin (IgE, IgG, IgA, and IgM). We use flow cytometry to quantify 
naive and non-naïve CD4 and CD8 T cells, natural killer cells, and B cells. We then discuss 
how these measures may be related to Tsimane health and life histories, and potential 
implications for public health in both pre-industrial and industrialised populations.
Methods
Study population
Since 2002 the Tsimane have participated in the THLHP. All Tsimane residing in ~90 study 
villages are eligible to participate, and most choose to do so at least once. To date, 44,635 
medical exams have been conducted along with 20,268 biospecimen collections from 8,569 
individuals. Prior to 2010, data was collected in 33 villages by mobile medical teams, with 
all individuals present in the village encouraged to participate. However, since the Tsimane 
are a rapidly expanding population, there are many more young people than old. In an effort 
to increase sampling across older ages, beginning in 2010 an additional 44 communities 
were sampled and all individuals over age 40, as well as their dependent children, were 
offered transport to the town of San Borja (pop. ~25,000) for exams in our permanent clinic. 
Data for this study includes individuals from 77 communities, including ~90% of the 
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population over age 40 and ~40% of adults and children under 40. The Tsimane 
ethnographic context and project details, including methods of demographic data collection, 
have been described in further detail elsewhere (Gurven et al., 2007; Blackwell et al., 2011).
Ethics approval
The study was reviewed and approved by the Gran Consejo Tsimane, the governing body 
overseeing Tsimane affairs and research projects, and by the IRBs of the University of 
California-Santa Barbara (UCSB) and the University of New Mexico. Informed consent was 
obtained at two levels. During a community meeting open to all residents, communities 
decided collectively whether the study would be conducted. To date, all communities that 
have been approached have approved the study. Individuals in the study also gave informed 
consent before each medical visit and interview. For minors, both parental consent and child 
assent was obtained.
Medical surveillance
Study participants were seen by the mobile THLHP biomedical team who visited Tsimane 
villages roughly once per year from 2004–2013. Beginning in 2010, some patients were also 
transported to our clinic in San Borja for exams. Patients seen by THLHP physicians were 
given routine physical exams (including medical history, symptom investigation and clinical 
diagnoses, blood pressure and temperature, anthropometrics). Following on-site analysis of 
blood and fecal samples for indicators of infection, physicians administered vitamins and 
medications as warranted.
Blood sample collection
For most participants blood was collected by venipuncture in a heparin-coated vacutainer. 
For infants <2 years old, blood was drawn with a capillary heel or finger prick, into a 
collection tube with heparin. Immediately following the blood draw, total leukocyte counts, 
lymphocyte/monocyte counts, hemoglobin, red blood cell count, and granulocyte count were 
determined with a QBC Autoread Plus dry hematology system (QBC Diagnostics), with a 
QBC calibration check performed daily to verify QBC performance. Relative fractions of 
neutrophils, eosinophils, lymphocytes, basophils, and monocytes were determined manually 
by microscopy with a hemocytometer by a certified Bolivian biochemist. ESR was 
calculated following the Westergren method (Westergren, 1957).
Total leukocytes as determined by hemocytometer counts were highly correlated with total 
leukocytes by QBC (r = 0.76, p <0.001), though QBC values were on average ~15% higher. 
Manual lymphocyte counts and neutrophil counts were also highly correlated with QBC 
counts (r = 0.84, p<0.001; r = 0.59, p<0.001). Over the course of 10 years of data collection, 
7 certified biochemists performed 98% of the manual differentials. Each examined different 
patient samples, but obtained similar median differentials: neutrophils (42–54%), 
eosinophils (13–20%), basophils (0% for all biochemists), lymphocytes (28–34%), and 
monocytes (0–1%). In a direct comparison of three of these biochemists independently 
performing manual differentials on three patient samples, coefficients of variation (CVs) for 
neutrophils, eosinophils, basophils, lymphocytes, and monocytes were 2.18%, 1.85%, 
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0.26%, 1.99%, and 0.35%, respectively. Median erythrocyte sedimentation rates were also 
similar across biochemists (range: 24–31 mm/h).
Flow cytometry
25ul of fresh, whole, heparinised blood was incubated with multiple combinations of 
fluorescently labeled antibodies (eBioscience, Inc.) for CD4 (PE or FITC, Clone RPA-T4), 
CD8 (APC, RPA-T8), CD19 (APC, SJ25C1), CD56 (PE, CMSSB), and CD45RA (PerCP-
Cy5.5, HI100). Following incubation for 30 minutes at 4°C, 500ul 1-step Fix/Lyse 
(eBioscience #00-5333-57) was added and blood was incubated an additional 30 min. 
Samples were then centrifuged, the supernatant was discarded, and cells were resuspended 
in 100ul PBS. Samples were read on an Accuri C6 Flow Cytometer (BD Accuri 
Cytometers). Given the large number of samples, FCS data files were exported from CFlow 
Plus (BD Accuri Cytometers) and imported into R 2.14.1. Cells were gated for lymphocytes 
using lymphGate from the Bioconductor package for R (http://www.bioconductor.org/) and 
florescence gates were determined using a combination of Bioconductor rangeGate and 
custom R scripting written to find low points in density functions. T cells were classified as 
CD4+CD8− helper or CD8+CD4− cytotoxic, and were further divided into naïve (CD45RA
+) and non-naïve (CD45RA-) subsets. B cells were identified as CD19+ and natural killer 
cells as CD56+CD8−CD4−. Absolute counts were calculated by multiplying the relative 
percentages determined by flow cytometry by the total lymphocyte count obtained from the 
QBC Autoread Plus. CD4, CD8, Natural Killer, and B cell percents were measured in 
duplicate. Mean CVs across duplicates were 15.6%, 15.2%, 15.3% and 18.9%, respectively. 
Some individuals were also measured at multiple timepoints, indicating consistency in 
individual measures across time (see Results section).
Serum biomarkers
Serum immunoglobulins from samples collected in 2004–2006 were measured by TriCore 
Laboratories (Albuquerque, NM) using an Immulite 2000 (Siemens Corp; Deerfield, IL). An 
additional 652 IgE and IgG levels were quantified at the University of Oregon (UO) by 
ELISA (Bethyl Labs, Inc.: #E80-108, #E80-104 and #E101). IgE samples at UO were run in 
duplicate. Mean within and between plate CVs were 3.7% and 8.6%. Liquichek 
Immunology Controls (BioRad) were also run and fell within the manufacturers 
specifications. Distributions of IgE samples measured by ELISA did not differ from earlier 
distributions obtained by Tricore (Kolmogorov–Smirnov test: D = 0.05, p = 0.83). IgE 
values for individuals measured by both laboratories from samples taken at different times 
were also highly correlated (see Results).
For IgG values run at UO, mean within and between plate CVs were 4.8% and 18.8%, 
respectively. Distributions between the two labs differed significantly (Kolmogorov–
Smirnov test: D = 0.20, p < 0.001), but were similar enough that these differences do not 
change interpretation relative to other populations: e.g. percentiles for Tricore and UO, 
respectively, were 10th: 1,458 and 1,510, 25th: 1,719 and 1,680, 50th: 2,071 and 1,910, 75th 
2,541 and 2,200, and 90th 2,964 and 2,492 mg/dL. As with IgE, IgG values for the same 
individuals measured at different times and analysed by different labs were correlated, 
though more weakly (see Results).
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CRP was measured in two batches, a first batch (n=650) was measured at the UO, and a 
second (n=885) at UCSB’s Human Biodemography lab via enzyme immunoassay (Brindle 
et al., 2010). Results from both the UO and UCSB laboratories were validated against one 
another with matched samples, and then further validated against the University of 
Washington Medical Center (UWMC), which was responsible for analysing samples for the 
National Health and Nutrition Examination Survey (NHANES), which is used here as a 
comparison group. Twenty seven serum specimens ranging in CRP from 0.08− 27.33 mg/dL 
were sent to UWMC, where serum was analysed for CRP via nephelometry using the same 
protocols and equipment as NHANES III (Wong et al., 2001). Results from UWMC were 
highly correlated r2=0.973, p<0.001 and not statistically different according to Tukey’s HSD 
(Mean difference = 0.01, HDS= 0.0096). For UO samples, mean within plate CV was 3.8%. 
Between plates, CVs were 12.7% and 9.9% for the high and low controls. At UCSB, within 
and between plate CVs were 7.3% and 10.2% for the high and 5.3% and 9.2% for the low 
controls.
Sampling schedule and inclusion criteria
Given the longitudinal nature of medical surveillance, measures were added and removed 
during different sampling rounds, and sampling procedures were sometimes affected by 
logistical difficulties (e.g., weather related transportation issues, reagent availability). Final 
sample sizes therefore vary by measure, and some individuals were measured repeatedly in 
multiple years. Blood differentials were collected for all individuals at all medical exams. 
Immunoglobulins and CRP were measured on multiple subsets of random individuals, 
stratified to sample across a range of ages. Flow cytometry was measured on all individuals 
brought to the THLHP clinic in San Borja between late 2011 and 2014. Number of 
individuals and number of observations for each set of measures are as follows: IgE 
811/902, IgG 1062/1286, IgA and IgM 604/604, CRP 1308/1828, blood differential 
6338/11812, and flow cytometry 1434/1734. Number of observations by age group are given 
in Tables 2–4. The temporal overlap of immunological measures collected by the THLHP is 
shown in Figure 1. Since infections and other medical complaints are common, with <10% 
of individuals having no medical complaint at any medical visit, we have not excluded 
individuals with medical complaints from analysis.
Analysis
Many blood markers have skewed distributions, making presentation of results in terms of 
mean and standard deviation problematic. For simplicity, we therefore present descriptive 
results in terms of the median value and the 5th and 95th percentile values. Since most 
individuals were measured only once, except for blood differentials where most were 
measured twice, we present the distribution of values for each measure and have not 
adjusted for repeat sampling of some individuals. Results are compared to values from 
published reference ranges (Hollinger and Robinson, 1953; Jolliff et al., 1982; Bofill et al., 
1992; Wetteland et al., 1996; Shearer et al., 2003; Bisset et al., 2004; Jentsch-Ullrich et al., 
2005) as well as values from NHANES 2005–2006 and 2009–2010 (http://www.cdc.gov/
nchs/nhanes.htm). Some published reference values include non-equivalent ranges (e.g. 10th 
– 90th or 2.5th – 97.5th instead of 5th to 95th). For these reference ranges approximate 5th and 
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95th percentile values were estimated by assuming log-normality and using the following 
equation to adjust the provided values:
where x̃ is the median, value is the provided upper or low interval value, and Zscore is the 
number of standard deviations the provided percentile value is from the mean in a normal 
distribution (e.g. 1.96 for the 97.5th percentile). To test whether Tsimane values differ from 
reference medians we use an exact binomial test to determine whether the proportion of 
Tsimane values falling above or below the reference median is significantly different from 
0.5.
For basophils and monocytes, a large number of individuals had zero counts. However, these 
zeros may have been due to sampling only 100 cells per individual for blood differentials. To 
estimate the most likely underlying distributions given the observed data and sampling, we 
fit zero-inflated Poisson models using map, in the rethinking package (McElreath, 2015), 
and then generated prediction medians and 95% intervals from the maximum a posteriori 
distribution. Intraclass correlation coefficients (ICCs) were estimated with ICCest in the ICC 
package, using only data for individuals with at least two observations. All analyses were 
conducted in R 3.2.1.
Results
Tsimane have elevated inflammatory biomarkers
Tsimane children have elevated CRP compared to the US reference (Table 2; Figure 2). 
Median CRP in children <18 years old is 1.21 mg/L, compared to 0.40 mg/L in NHANES. 
Ninety four percent of Tsimane children have CRP greater than the NHANES median (exact 
binomial test of 50% proportion, p<0.001), and 9.9% of Tsimane children have CRP ≥ 10 
mg/L, the cutoff commonly used as a clinical indicator of acute infection. Even excluding 
those with CRP ≥ 10 mg/L, median CRP in Tsimane <18 years old is 1.12 mg/L. In contrast, 
Tsimane ages 18–50 years have median CRP of 1.74 mg/L, and Tsimane age 50+ have 
median CRP of 2.30 mg/L, neither of which are significantly different from median values 
of 1.80 mg/L and 2.50 mg/L in NHANES.
ESR is also significantly elevated compared to reference values. However unlike CRP, ESR 
is elevated across all age groups. Median ESR values are around 30 mm/h in all age groups 
(Table 3). In US populations, above 15–20 mm/h is generally considered elevated, though 
the cutoff varies slightly by age and sex (Wetteland et al., 1996). Ninety-five percent of 
Tsimane have ESR values exceeding these references medians.
Tsimane have elevated lymphocytes, neutrophils and eosinophils, but lower monocytes 
and basophils
Tsimane total leukocyte (WBC) counts are consistently elevated relative to US references 
(Table 3). Median WBC values by age group range from 12.0×103 cells/μl in children <6 
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years old to 8.6×103 cells/μl in adults aged 50+. Comparable values in NHANES are 7.9 and 
6.7×103 cells/μl, making Tsimane values approximately 1.5 times higher. Elevations are 
apparent in most, but not all WBCs. Lymphocytes and neutrophils are elevated by 1.2–1.6 
times reference medians (Table 3; Figure 2). Eosinophils, which respond to parasitic 
infections, are the most dramatically elevated, with counts ~7 times higher than reference 
values in young children and adults, and ~10 times higher in juveniles and adolescents 
(Figure 3). Ninety-seven percent of Tsimane have eosinophil values higher than the 
NHANES median, and 89% have counts higher than the NHANES 95th percentile.
In contrast, monocytes and basophils are rarely detected in Tsimane samples (Figure 2). 
Seventy two percent of Tsimane have no monocytes observed in manual cell counts, and 
<1% have basophils observed (Table 3). This is unlikely to be due to human error, as low 
monocyte and basophil counts have been observed by seven different certified biochemists 
consistently over ten years. However, rare monocytes and basophils might have been 
overlooked since biochemists counted only 100 cells to determine differentials. To address 
this, we used a zero-inflated Poisson model to estimate the likely posterior distribution for 
cell counts given observations with counts of 100 cells. For monocytes, the median of the 
posterior is 119 cells/μl (95% prediction interval: 99 – 137 cells/μl). For basophils, the 
posterior distribution is estimated to be only 14 cells/μl (95% prediction interval: 0 – 30 
cells/μl). Both of these values are significantly below reference ranges (Figure 2), with 
basophils ~20% of reference values and monocytes ~35%.
Tsimane have elevated natural killer cell counts
In American and European populations, natural killer cell concentrations decline with age. 
For Tsimane, precisely the opposite is observed as concentrations are higher in older age 
groups. Tsimane children <5 years old have natural killer cell counts that resemble reference 
populations, while juveniles and adolescents have roughly double the number of cells seen 
in age-matched Americans and Europeans, and adults roughly triple the number (Table 4; 
Figure 1).
Tsimane have elevated immunoglobulin and B cell levels throughout life
Tsimane have elevated levels of all major classes of immunoglobulins across all ages (Table 
2; Figure 3). Total level of serum IgM, the class of antibody produced immediately upon 
exposure to a novel antigen, is elevated in Tsimane children ≤ 5, with median concentration 
1.7 times higher than US children and a positively skewed distribution. Relative elevation of 
IgM declines by age group, but is significantly higher at all ages (Figure 3). Median 
concentrations of serum IgE, a class of antibodies produced in response to macroparasitic 
infections such as helminths, are 150–200 times higher in Tsimane than in age-matched 
Americans, with 100% of Tsimane having IgE above reference medians. Distributions of 
total serum IgG and IgA levels are approximately double US reference distributions, with 
<1% of Tsimane having IgG lower than the reference median and 6% having lower IgA than 
the reference median.
Consistent with the pattern of elevated immunoglobulins, Tsimane adolescents and adults 
have roughly twice as many B cells as American and Swiss reference populations (Table 3; 
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Figure 3). In both Tsimane and reference populations, B cell counts are lower in older age 
groups; however, this decline is attenuated among Tsimane. (Table 4).
Tsimane naïve CD4 T-cell pool declines with age, while the naïve CD8 T-cell pool is 
maintained
Tsimane children ≤ 5 years old do not have significantly different numbers of CD4 helper T-
cells than reference populations (Table 4; Figure 4). However, Tsimane have significantly 
more CD4 cells from ages 6–18 years, and significantly fewer cells in both adult age groups. 
When naïve and non-naïve (i.e. memory) pools are examined separately, we find that 
Tsimane have significantly elevated non-naïve CD4 cells at all ages. Naive CD4 cells show a 
pattern of increased production through childhood, followed by greater depletion in 
adulthood; Tsimane children ages 6–17 years have significantly more naïve CD4 cells than 
reference populations, while adult Tsimane have significantly fewer cells.
Across age groups, median Tsimane total CD8 T-cell counts are moderately higher than in 
reference populations, though with considerable overlap in distributions. Across all age 
groups, Tsimane naive CD8 counts are about 20% higher than a Swiss reference sample. 
Non-naïve CD8 cells are moderately higher in mid-childhood, and appear to maintain 
similar levels into adulthood. This stands in contrast to the reference sample where non-
naïve CD8 cells are higher in adults, exceeding Tsimane values.
Ratios of CD4 to CD8 cells are commonly used as a diagnostic tool for immunosuppression, 
and in particular in monitoring HIV progression. Overall Tsimane CD4/CD8 ratios are 
similar to reference values, with medians ranging from 1.5 to 1.7 across age groups (Table 
4). In both adult groups, Tsimane CD4/CD8 ratios are moderately lower than in reference 
populations, reflecting the slightly higher CD8 counts and slightly lower CD4 counts in 
these age groups.
Immunological values are consistent for individuals across multiple measurements
Differences between Tsimane and reference populations might be due to consistent 
differences between individuals or due to frequent acute infections in the sample. We 
investigated the stability of immunological measures by calculating the ICCs for each 
measure for individuals with at least two measurements. ICCs for monocyte and basophil 
counts were low due to very little variance in these measures (most individuals had zero 
cells detected and the difference between zero and one was essentially a random draw). 
Apart from these two measures, ICCs ranged from 0.20 to 0.81 (Table 5), indicating that 
between 20% and 81% of the variance in these measures was due to between individual 
differences. The lowest ICC was for neutrophil count (ICC = 0.20, CI 0.17–0.23), possibly 
indicative of fluctuations from acute infections. The ICC for CRP, also commonly used as a 
marker of acute infection, was 0.49 (CI 0.42–0.55), suggesting both significant between and 
within individual differences. Naïve CD4 (ICC = 0.73, CI 0.67–0.78) and CD8 (ICC = 0.72, 
CI 0.65–0.77) cells were highly stable across measurements, as were B cells (ICC = 0.68, CI 
0.61–0.74). Immunoglobulin E levels were incredibly stable, even with measurements an 
average of four years apart (ICC = 0.81, CI 0.72–0.87).
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Discussion
Tsimane live in a highly pathogenic environment and are chronically infected with a wide 
range of pathogens and parasites. Our results show that this environment has dramatic 
consequences for immune function. Relative to industrialised populations Tsimane show 
elevations in most measures of immune function across all age groups, including levels of all 
four major classes of antibodies, levels of lymphocytes and many lymphocyte subsets, 
neutrophils, eosinophils, and ESR. Compared to reference populations, the most dramatic 
elevations are in immunological responses to extra-cellular parasitic infections, and in 
particular IgE and eosinophils (Figure 5). Elevations in natural killer cells may also be 
related to helminth infections, as some reports suggest that helminths, and in particular 
hookworm, may selectively activate natural killer cells and lead to expansions of natural 
killer cell lines (Korten et al., 2002; Hsieh et al., 2004; Anthony et al., 2007).
Other elevated immune parameters are harder to pin to specific infections because they are 
less specific to particular infections. Levels of other immunoglobulins and B cells likely 
represent general increases in humoral immunity, although they may also be secondary to 
shifts in T cell populations towards TH2 biased immune responses, again, possibly due to 
helminth infections (Maizels and Yazdanbakhsh, 2003). High ESR in the absence of elevated 
CRP has been reported as a component of a number of other conditions, including anaemia 
and pregnancy, but most predominant among these are conditions involving excess 
production of immunoglobulins, such as Schnitzler’s syndrome and Waldenstrom’s 
macroglobulinemia (Nashan et al., 1995; Ghobrial et al., 2003). Although these conditions 
involve cancerous expansion of B cell lines, Tsimane immunoglobulin levels are just as 
high, though presumably not of cancerous origin given that these are population wide 
elevations. ESR may also be elevated in some chronic conditions such as tuberculosis with 
also afflicts many Tsimane.
Monocytes and basophils are rarely observed in Tsimane blood differentials. Basophils are 
rare in venous blood samples in other populations as well; in the NHANES data basophils 
accounted for only 0.6% of leukocytes. In our study we estimate basophils account for only 
0.1% of Tsimane leukocytes. We estimate monocytes represent 1.1% of leukocytes, far less 
than ~7% in reference populations. Basophils contain heparin, which slows clotting, and 
histamine to promote blood flow to tissues. They also have protein receptors that bind IgE. 
Monocytes differentiate into macrophages and dendritic cells to mount immune responses at 
localised sites of infection. Thus, both cell types exist in the blood primarily to mobilise and 
act at the sites of injury and invasion. We suggest that the low levels of basophils and 
monocytes in the blood may be a consequence of migration of these cells to the sites of 
helminth infections, injuries, and ectoparasitic invasions.
Age-Related Differences
Several markers show distinct differences across age groups. In reference populations, CRP, 
IgM, and neutrophil counts are higher in older ages, while in Tsimane median levels of these 
three markers are relatively consistent across age groups, meaning that Tsimane children 
have high relative levels (Figure 5). These three measures likely represent exposure to novel 
pathogenic stimuli. IgM is produced in response to novel antigen exposure. CRP is an acute 
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phase reactant and part of the innate immune response, produced rapidly during early phases 
of infection. Neutrophils, similarly, are innate phagocytic cells that are on the “front line” of 
immune defenses. These results are therefore consistent with the observation that Tsimane 
are exposed to high levels of pathogens and parasites, beginning at young ages.
In reference populations and Tsimane, CD4, CD8, and B cells are highest at younger ages 
and lower in older ages. For T cells, where we have divided the sample into naïve and non-
naïve cells, it is clear that this decline is driven by decreases in naïve cell pools. This is 
consistent with a life history perspective (McDade, 2003); children are born without 
immunological experience, and to acquire adaptive immunity they must generate a large 
pool of diverse naïve cells and then select from among this pool. As naïve cells are selected 
for antigen reactivity, libraries of memory T and B cells and immunoglobulins are generated. 
As children age, the demand for naïve cells declines, as fewer novel antigens are 
encountered. Naïve cells can be thought of as investments into future defense; given the 
costs of maintaining naïve cell pools, the payoffs to investment in naïve pools declines as 
they become both less necessary and the length of future lifespan declines.
Past results suggest that Tsimane infants have smaller thymic volumes than comparable 
infants from a Turkish sample, but larger thymic volume than Venezuelan Pumé infants of 
the same size (Veile et al., 2012). Despite variable thymic size across populations, it does not 
appear that the production of naïve T-cells is affected, as Tsimane children <5 years have 
comparable naïve T-cell counts when compared to US children. Unlike in mice, the majority 
of peripheral T cells in humans are actually produced through proliferation of naïve cells, 
rather than through thymic output (den Braber et al., 2012). The thymus then, is required for 
the production of T cells with novel receptors, but not for maintenance of the overall naïve 
pool.
Compared to reference populations, Tsimane show slightly higher naïve CD4 cells in mid-
childhood and adolescence, followed by much lower naïve CD4 pools in adulthood. 
Previous reports of depleted CD4 cells have suggested that chronic helminth infection may 
be involved (Kalinkovich et al., 1998; Borkow et al., 2000; Tsegaye et al., 2003). This would 
certainly be consistent with the other immunological parameters we have measured. 
Whether this decrease is due to a change in thymic output or through reduced peripheral 
proliferation remains to be seen, and will require measurements of thymic size, or markers 
such as T cell receptor excision circles (Gruver and Sempowski, 2008). In contrast, naïve 
CD8 cells are retained at high levels.
There are two possible interpretations of this difference between CD4 and CD8 cells. One is 
that increased exposure to bacteria, helminths, fungi, and protozoa depletes naïve CD4 
reserves. The other is that large pools of naïve CD4 cells may not be necessary, since novel 
helminths, protozoa, fungi, and bacteria may be rare, with many of these infections likely to 
be chronic or repeated throughout the Tsimane lifespan (e.g. giardia and helminths 
(Blackwell et al., 2013)). In contrast, naïve CD8 pools might be retained because novel viral 
infections are common, given the rapid pace of viral evolution and direct communicability 
between individuals. Given the high costs of maintaining immunity, we expect natural 
selection to have produced mechanisms for regulating these pools carefully in response to 
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the pathogenic environment, perhaps by using early life immune activation of different cell 
lines as a cue for setting later allocation levels.
Life history trade-offs and the costs of immune defense
Immune function is costly, and elevations in immunity are likely to have significant costs for 
Tsimane and other Amazonian populations. Fever, for example, increases metabolic rate by 
13% for every degree increase in body temperature, while sepsis or systemic infection can 
increase metabolic costs by 50% (Lochmiller and Deerenberg, 2000). Protein synthesis 
increases during an immune response, from about 3.5g to 6g of protein per day per kilogram 
of body weight, an estimated expense of 285 kcal/day (McDade, 2003). Tsimane and other 
Amazonians are of small stature relative to international standards and are relatively lean but 
not underweight (Gurven et al., 2012a; Urlacher et al., 2015). Past studies of Tsimane and of 
Shuar, an Ecuadorian forager-horticultural population, have shown trade-offs between 
immune response and growth rates in children (McDade et al., 2008; Blackwell et al., 2010), 
and associations between IgE and the height of adolescents and adults (Blackwell et al., 
2010). The results presented here suggest that high IgE is likely to be accompanied by 
elevations in many other immunological parameters, meaning that IgE levels may simply be 
indicative of much broader costs imposed by parasitic infections. This may help explain the 
strong inverse association between IgE and growth outcomes.
During growth, Amazonians also appear to prioritise weight gain over skeletal growth and 
height attainment (Blackwell et al., 2009; Stieglitz et al., 2015a), and they also seem to 
accumulate fat in central locations where it may be particularly important for fueling 
immune defenses (Urlacher et al., 2015). Tsimane also have high resting metabolic rates and 
total daily energy expenditures, as measured by doubly labeled water and respirometry 
(Gurven et al., 2016). All of these characteristics are likely to relate to the allocation of 
resources towards immune function, as additional energy is used and stored for maintenance 
rather than growth. Resources may also be directed away from some reproductive costs, at 
least in males, as Tsimane have low levels of testosterone (Trumble et al., 2012) and smaller 
prostate sizes (Trumble et al., 2015) compared to age matched men from industrialised 
populations.
Consequences for non-infectious disease
With effects on energy balance and mobilisation, it should be apparent that immune 
activation in Amazonians may have implications for fat deposition and the development of 
obesity and obesity-related diseases, particularly as these populations begin to integrate into 
markets and gain access to sanitation and hygiene that reduces pathogen exposure. 
Inflammatory processes have also been implicated in other metabolic and cardiovascular 
health outcomes. Inflammatory cytokines lead to inflammatory responses in adipose tissue, 
that promote local insulin resistance (Gustafson et al., 2007) and inflammation contributes to 
stress dependent hypertension (Marvar et al., 2012). Inflammation also mediates the 
pathogenesis of atherosclerotic plaques, with both innate and adaptive immunity responding 
to plaque antigens (McLaren et al., 2011; Wigren et al., 2012). Plaque antigens stimulate 
recruitment of monocytes to form macrophages that engulf lipids and transform them into 
lipid-laden foam cells. With plaque formation, the lesion does not resolve and a pro-
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inflammatory environment is created, which in turn recruits more monocytes, leading to 
formation of a lipid-rich necrotic core (Spagnoli et al., 2007; Moore and Tabas, 2011).
Notably, obesity, hypertension, atherosclerosis, and diabetes are largely absent in the 
Tsimane (Gurven et al., 2009, 2012a), despite apparent elevations in some inflammatory 
markers and a highly pathogenic environment. In the case of atherosclerosis, this may be due 
to recruitment of monocytes to non-arterial locations, meaning that monocytes that 
differentiate into macrophages do not respond to plaques. Tsimane blood lipid levels are also 
substantially lower than in other populations, which may be due in part to parasitic 
infections (Vasunilashorn et al., 2010). With effects on energy balance, pathogen stress may 
counteract obesity. Inflammation may also be better regulated, as helminths and other 
parasites induce regulatory and TH2 responses (McDade et al., 2012; Blackwell et al., 2015).
Limitations and future directions
We have characterised immune function in an Amazonian population exposed to high 
prevalences of pathogens and parasites. However, we have not directly tested for 
associations between particular infections and immunological effects, and we caution that 
conclusions about causality should be considered speculative until additional analyses, 
experiments, and observations can establish definitive links. Other environmental factors, 
such as diet, nutrition, and physical activity may play important roles in cross-population 
immunological differences. Moreover, some differences between Tsimane and industrialised 
populations may be due to genetic, rather than environmental differences. Analysis of a 
handful of Tsimane genes do show differences in the frequencies of some immune related 
genes, though how these link to phenotypes is somewhat unclear (Vasunilashorn et al., 
2011). Future analysis of both genetic and environmental variance will be needed to 
elucidate how genes and environments interact to produce Tsimane immunological patterns. 
Finally, additional longitudinal data is needed to establish whether age patterns are due to 
developmental or cohort effects.
Conclusions
This comprehensive view of Tsimane immune function makes it clear that Tsimane differ 
from US and European populations on many immunological parameters. The most dramatic 
of these differences are likely related to chronic helminth infections, including elevated IgE 
and eosinophils. Other differences, such as elevated natural killer cells and depleted naïve 
CD4 cells may have a related etiology. These differences help us to understand patterns in 
Tsimane life history and health, and represent a first step in understanding cross-cultural 
diversity in immune function. While our focus here is on Tsimane immune function, chronic 
helminth infection, diverse bacterial and viral pathogens, and fungi are common features of 
many Amazonian populations, and so the overall portrait of immune function described here 
should be generalisble to other populations inhabiting similar infectious environments. By 
understanding how human immune function varies in response to ecological conditions, we 
can begin to elucidate the functional design of immunological reaction norms, and better 
understand how human immune function evolved. By understanding immune function as a 
plastic and dynamic system, we can begin to reason about how this system responds in both 
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high pathogen and low pathogen environments, with consequences for the disease 
epidemiology of both infectious and non-infectious diseases.
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Figure 1. 
Tsimane sampling history. Darker shading indicates that more samples were analysed at a 
given time-point.
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Figure 2. 
Innate immune responses in Tsimane (red) and reference populations (blue). Shading 
indicates the 5th and 9th percentiles, solid lines the median value. Note y-axes are logged 
except for ESR and basophils.
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Figure 3. 
Humoral and TH2 activated immune responses in Tsimane (red) and reference populations 
(blue). Shading indicates the 5th and 9th percentiles, solid lines the median value. Note y-
axes are logged.
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Figure 4. 
Naïve and non-naïve T cell counts in Tsimane (red) and reference populations (blue). 
Shading indicates the 5th and 9th percentiles, solid lines the median value. Note y-axes are 
logged.
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Figure 5. 
Ratio of median Tsimane immunological values to median values from reference 
populations, by age group. Note the y-axis is logged and discontinuous.
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Table 1
Immunological parameters measured in this study
Name Description
Immunoglobulins Also known as antibodies. Small molecules secreted by plasma cells which bind to specific antigens on 
pathogens or parasites. Immunoglobulins possess a hypervariable region produced through random 
recombination of gene segments.
 IgG The most common class of antibody. Important in immunological memory of previously encountered 
antigens. The only class of antibody that can cross the placenta and protect a foetus.
 IgE In most populations, the least common class of antibody, but produced in much higher levels in many 
Amazonian populations (Blackwell et al., 2011; Martin et al., 2013). Produced in response to 
macroparasitic infections and also in allergic responses.
 IgM Predominates in the primary immune response to a novel antigen.
 IgA Often studied in its secretory form in saliva and other mucosal secretions. Serum IgA may serve as a 
second line of defense when mucosal membranes are breached (Woof and Kerr, 2004).
Leukocytes All white blood cells
 Neutrophils Abundant granulocytes that respond to acute infections by migrating to sites of infection where they 
phagocytise invading microbes.
 Basophils The least common granulocyte. Bind IgE and aid in defense against macroparasites and in allergic 
responses. Migrate to the invasion sites of ectoparasites such as ticks and mosquitos. Secrete IL-4 and 
stimulate IgE production.
 Monocytes Phagocytic cells that migrate to infections and injuries where they differentiate into macrophages.
 Eosinophils Defend against macroparasites and contribute to allergic responses. Activated by cytokines secreted by 
Type 2 helper T cells
Lymphocytes Characterised by the presence of CD45 and by size and granularity in flow cytometry.
 Helper T cells (CD4) Recognises specific antigen to signal CD8 and macrophages to kill. Signals B cells to produce antibody. 
Both CD4 and CD8 T-cells have unique T-cell receptors on their surfaces produced by rearrangement of 
gene segments.
 Cytotoxic T cells (CD8) Induce apoptosis in cells infected with viruses or other intracellular pathogens.
  Naïve T cells Both CD4 and CD8 T cells begin life as naïve cells which have not been previously exposed to antigen. 
Naïve cell pools consist of many different lineages with randomly generated T-cell receptors that have not 
been selected upon for antigen reactivity.
  Non-naïve T cells When naïve T cells encounter an antigen to which they can bind, they undergo clonal expansion, becoming 
effector, memory, and regulatory T cells. These daughter lineages retain the antigen specificity of the 
original clone.
 B cells Recognises specific antigens. Includes plasma cells which produce immunoglobulins.
 Natural Killer Cells Kills virally infected cells by recognising non-specific molecules. May also play a role in defense against 
helminths.
Inflammatory Markers
 Erythrocyte Sedimentation 
Rate (ESR)
The rate at which red blood cells (erythrocytes) sediment to the bottom of a capillary tube. Used as an 
inflammatory marker since it is primarily related to the presence of fibrinogen, which facilitates blood 
clotting and is elevated as part of the acute phase response.
 C-reactive Protein (CRP) An acute phase reactant produced in response to inflammation. Binds to dead or dying cells and bacteria to 
promote phagocytosis. Elevated in acute infection and for one to two weeks after. Is frequently elevated in 
Amazonian populations, though baseline levels may not be high (McDade et al., 2005, 2012; Gurven et al., 
2008; Blackwell et al., 2010).
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Table 5
Intraclass correlation coefficients
Variable ICC N k Δ Years
IgE 0.81 (0.72–0.87) 91 2.0 3.95
IgG 0.38 (0.26–0.49) 224 2.0 3.99
Leukocytes 0.37 (0.35–0.39) 2846 2.9 2.24
Lymphocytes 0.49 (0.46–0.51) 1917 3.0 2.05
Neutrophils 0.20 (0.17–0.23) 1917 3.0 2.05
Basophils 0.13 (0.10–0.15) 1916 3.0 2.05
Eosinophils 0.30 (0.27–0.33) 1917 3.0 2.05
Monocytes 0.08 (0.05–0.10) 1917 3.0 2.05
CRP 0.49 (0.42–0.55) 473 2.1 2.48
ESR 0.35 (0.32–0.37) 2095 3.0 2.16
CD4 0.67 (0.60–0.73) 255 2.1 1.24
Naïve CD4 0.73 (0.67–0.78) 251 2.1 1.24
Non-Naïve CD4 0.30 (0.19–0.40) 251 2.1 1.24
CD8 0.69 (0.62–0.75) 255 2.1 1.24
Naïve CD8 0.72 (0.65–0.77) 251 2.1 1.24
Non-Naïve CD8 0.55 (0.46–0.62) 251 2.1 1.24
Natural Killer Cells 0.30 (0.19–0.40) 255 2.1 1.24
B Cells 0.68 (0.61–0.74) 255 2.1 1.24
log(CD4/CD8 Ratio) 0.41 (0.31–0.51) 255 2.1 1.24
ICC = estimate and 95% confidence intervals for the intraclass correlation coefficient, i.e. the proportion of variance attributable to between 
individual differences. N = number of unique individuals. k = mean number of observations per individual. Δ Years = mean time in years between 
observations. Analysis only includes individuals with at least two observations.
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